Navigation Links
NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO
Date:5/16/2008

The following news tips are based on abstracts or poster presentations at the annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 June 3, 2008.

Study Tracks a Biomarker for Early Detection of Malignant Pleural Mesothelioma

Abstract # 11074: Plasma osteopontin is an early detection and prognostic marker in malignant pleural mesothelioma
NYU Cancer Institutes Harvey Pass, M.D., professor of cardiothoracic surgery and surgery; division chief of thoracic surgery and thoracic oncology, at NYU Langone Medical Center

NYU Langone Medical Center researchers and their colleagues are making strides to find a way to reliably screen for pleural mesothelioma, which threatens an estimated 7.5 million workers in the United States who have been exposed to asbestos. The level of osteopontin (OPN), a protein biomarker, in blood serum has been characterized as an early sign of pleural mesothelioma, a cancer of the chest cavity and lungs that is caused by exposure to asbestos. But recent assays have shown that plasma OPN levels are a more reliable indicator of this type of cancer. Researchers from NYU Langone Medical Center, Karmanos Cancer Institute, and University of Hawaii Cancer Center present a study showing that plasma OPN levels are a sensitive biomarker. They measured OPN levels in blood plasma of 39 mesothelioma patients and 79 asbestos-exposed individuals; plasma OPN levels appeared a sensitive discriminator for the development of pleural mesothelioma in these high-risk individuals.

Finding Novel Biomarkers for Mesothelioma with MicroRNAs

Abstract # 11027
NYU Cancer Institutes Harvey Pass, M.D., professor of cardiothoracic surgery and surgery; division chief of thoracic surgery and thoracic oncology, at NYU Langone Medical Center

Differential microRNA expression in pleural mesothelioma: Implications for early detectio
'/>"/>

Contact: Jennifer Berman
Jennifer.Berman@nyumc.org
212-404-3555
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts
2. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
3. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
4. Americans must consider cost and effectiveness when comparing and choosing medical interventions
5. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
6. Nonin(R) Medical Pioneers First Interoperable, Wireless Fingertip Pulse Oximeter
7. CRH Medical Corporation opens Center in New York
8. Mindray Medical Completes Acquisition of Datascopes Patient Monitoring Business
9. RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS
10. LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record
11. UNICEF Rushing Medical Supplies, Tents, Clean Water to Children Affected by Powerful Earthquake in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009).... 21 DNC Chairman Tim K...te voted to begin full debate of health insurance ...com.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "T... road to enacting health insurance reform. By clea...ow have an opportunity to debate the health reform...
(Date:11/21/2009)...scusses Key Provisions of Legislation, Continues P...CHARLES, Ill., Nov. 21 ...he landmark Affordable Health Care for America Act...orm legislation forward, Congress has taken decisi...stem. Today, AARP hosted an educational forum to ...
(Date:11/21/2009)...APPYneuron,s most popular and addictive game, Spli...uch. , Mountain View, CA ...pular and addictive game, SplitWords, is now avail...designed to help banish that ,tip of the tongue, s... game challenges the brain by encouraging users t...
(Date:11/20/2009)...logist Closer to Understanding Brain Wiring and Di...swire/ -- Dr. Jeremy Schmahmann, Professor of Neur... the Massachusetts General Hospital in Boston, on ...research on the new field of study called "Connect..., Dr. Schmahmann is an award-winning leader in ...
(Date:11/20/2009)...ov. 20 Following a recall by Unile...d from sale Shedd,s Country Crock ® Side Dish...y Crock ® Side Dishes DELUXE Four Cheese Past...e following code dates and UPCs are affected: ,... Cheddar Broccoli Rice 21 oz, UPC 027400218316, Be...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...-vaporizing device delivers the same level of acti...ogical effect as smoking cannabis , but without th... Results of a UCSF study, which focuses on d...rapeutics." "We showed in a recent paper i...
...ost as yet. But the massive wildfire along the Geo...and destroying smaller structures. There is no si...es west of U.S. 441 had to be evacuated for a seco...t of the roadway were still waiting to return. ...
...s bad tidings for those heavy-handed on multivitam...s National Cancer Institute , reveals that those w...k, can in fact increase their risk of contracting ...5,344 men who reported taking multivitamins more t...
...nt Nautilus has been awarded a record order worth ...in of health centers . This is the biggest ever or... in India. The order follows a joint ventu...malls across the country. The ambitious ve...
...was a centuries-old Indian tradition, popular yoga...rganizations to prevent it from being patented ov...ent this tradition (of yoga) in America, the India...e country and humanity. Also yoga cannot be run li...
...Canada has termed as thrilling and relieving, a...s him to a compensation of 130, 000 US dollars. ...insurer Ace Ina Insurer ,when they refused to pay ...est Nile virus. The accident took place in 2...
Other Medicine News:Health News:Smokeless Cannabis Delivery Device Found Efficient and Less Toxic 2Health News:Massive Wildfire Forces Evacuation of Hundreds of Home in Florida 2Health News:Being Overzealous With Multivitamins May Lead To Prostate Cancer 2
(Date:11/20/2009)...TON, Nov. 20 Cyberonics,...ore, President and Chief Executive Officer, and Gr...t the 21st Annual Piper Jaffray Health Care Confer... 12:00 PM EST. The conference session and webcast...resented. Piper Jaffray will host a webcast of th...
(Date:11/20/2009)...ETON, N.J., Nov. 20 Soli...or the Company), formerly known as DOR BioPharma, ...d today that it has formed a consortium to develop...other rapidly acting vaccines. Soligenix received ...f Allergy and Infectious Diseases (NIAID), a divis...
(Date:11/19/2009)...AND, Colo., Nov. 19 In a...s, experience, Heska Corporation (Nasdaq: HSKA ) ...nch of its new and improved website. The upgraded... design and programming to align the site with the...s. ,, (Logo: http://www.newscom.com/cgi-bin/...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Clinical and Histopathological Results Using Pollogens TriPollar 28TM 29 Radio Frequency Technology Published in the June Issue of the Journal of Cosm 4604 1Clinical and Histopathological Results Using Pollogens TriPollar 28TM 29 Radio Frequency Technology Published in the June Issue of the Journal of Cosm 4604 2Clinical and Histopathological Results Using Pollogens TriPollar 28TM 29 Radio Frequency Technology Published in the June Issue of the Journal of Cosm 4604 3Precision Stability Storage Announces Upcoming Expansion 12665 1Precision Stability Storage Announces Upcoming Expansion 12665 2Precision Stability Storage Announces Upcoming Expansion 12665 32009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 49156 12009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 49156 22009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 49156 3
...hase 1 results demonstrating clinical activity o...ients, previously treated with bortezomib, and pr...f perifosine in combination with dexamethasone, N...asdaq: KERX ) today announced that positive phase...ents with advanced, relapsed/refractory,multiple m...
...endamustine Produced a Significant Increase ...rvival, FRAZER, Pa., Dec. 10 Cephalon, Inc. (Nas... of treatment-naive patients,with chronic lymphocy...ndamustine HCl) had better clinical outcomes compa...approved therapy for patients with CLL.,TREANDA(R)...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 7TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 2TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 3TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 4TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil 5
...pace is a premium Fabius Tiro combines the latest ...ergonomic and compact design. Adding the ability a...nt monitoring range allows you to create yourself ... into the future. The open modular architecture an...
...Ohmedas unique approach to anesthesia workstation ...th clinicians. It combines the proven performance ...g technology into an affordable system solution de...contemporary, compact design addresses many ergono...
...sing is a sterile, single use bundle of absorbent ...s. The synthetic matrix absorbs excess exudate fl...entraps slough and necrotic debris within its stra...matrix are bound together by a matrix bridge to mi...
...ence card system as well as a perpetual inventory ...quirements of the surgical services department. Th...ay of inventory management capabilities enables th...charge capture workflow. Regardless of how supplie...
Medicine Products: